Helix Animation

Albatroz Therapeutics MOA - novel antibodies & AD 

Prev Next
Previous

Align iTero Training Videos

Next medical animation of Presenting Lys Therapeutics' groundbreaking mechanism of action of their main drug - a first-in-class monoclonal antibody - Glunozumab to pharma companies and potential investors in a clear, accurate and highly compelling way,

The unique MOA of Glunozumab

First-in-class therapeutic antibodies that block Calnexin, a novel tumor surface protein, that is critical to the tumor’s ability to degrade the extracellular matrix, a physical barrier preventing the growth of solid tumors in most organs of the body.

Keywords: Animation, 3D, Apps/Mobile, Video, VR/Virtual Reality, Cell biology / Histology, General Medicine, Oncology, Mechanism of Action (MOA), Pathology